Amlin Plc
AMLIN plc
OPTIONS EXERCISE AND SHARE CAPITAL UPDATE
Amlin plc ('Amlin') announces that those of the October 2002 grant of options
under its Savings-Related Share Option Scheme ('Scheme') which were linked to
three year savings contracts reached maturity on 1 December 2005.
A total of 395,244 Ordinary Shares of 25p have consequentially been issued to
employees under the terms of the Scheme, at an exercise price of 78.89p per
share (amount and exercise price as adjusted as a result of Amlin's recent
rights issue).
Following such issue, and the issue of further shares under other Amlin share
option schemes, the issued share capital of Amlin is now 530,025,347 Ordinary
Shares of 25p each, of which 127,805,073 shares (being those issued in the
recent rights issue) do not rank for the final dividend in respect of 2005.
Recently issued shares in respect of share options are included within current
block listings granted by the UK Listing Authority and the London Stock
Exchange.
Enquiries:
Charles Pender 020 7746 1000
Group Company Secretary
5 December 2005
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.